EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.90
-57.84% today
Updated 2026-05-05
Market cap
$547.78M
P/E ratio
3.92
P/S ratio
0.51x
EPS (TTM)
$2.36
Dividend yield
6.50%
52W range
$4 – $15
Volume
1.1M
Embecta Corp (EMBC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.90
12-Month target
$11.09
2030 Target
$8.81
Intrinsic (DCF)
$46.96
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -0.09% (capped 20%) · P/E: 3.92x (capped 25x) · Margin: 12.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.